Submit Feedback
Learn more about Thermo Fisher Scientific's Revenue by Segment and Revenue by Region.
Check out competitors to Thermo Fisher Scientific in a side-by-side comparison.
Explore additional financial metrics for Thermo Fisher Scientific.
| Year | Revenue |
|---|---|
| 2016 | 18274100000.00 |
| 2017 | 20918000000.00 |
| 2018 | 24358000000.00 |
| 2019 | 25542000000.00 |
| 2020 | 32218000000.00 |
| 2021 | 39211000000.00 |
| 2022 | 44915000000.00 |
| 2023 | 42857000000.00 |
| 2024 | 42879000000.00 |
| 2025 | 44556000000.00 |
| Period | Revenue |
|---|---|
| Apr 2016 | 4294800000.00 |
| Jul 2016 | 4535200000.00 |
| Oct 2016 | 4490900000.00 |
| Dec 2016 | 4953200000.00 |
| Apr 2017 | 4765000000.00 |
| Jul 2017 | 4990000000.00 |
| Sep 2017 | 5116200000.00 |
| Dec 2017 | 6047000000.00 |
| Mar 2018 | 5853000000.00 |
| Jun 2018 | 6078000000.00 |
| Sep 2018 | 5920000000.00 |
| Dec 2018 | 6507000000.00 |
| Mar 2019 | 6125000000.00 |
| Jun 2019 | 6316000000.00 |
| Sep 2019 | 6272000000.00 |
| Dec 2019 | 6829000000.00 |
| Mar 2020 | 6230000000.00 |
| Jun 2020 | 6917000000.00 |
| Sep 2020 | 8521000000.00 |
| Dec 2020 | 10550000000.00 |
| Apr 2021 | 9906000000.00 |
| Jul 2021 | 9273000000.00 |
| Oct 2021 | 9330000000.00 |
| Dec 2021 | 10702000000.00 |
| Apr 2022 | 11818000000.00 |
| Jul 2022 | 10970000000.00 |
| Oct 2022 | 10677000000.00 |
| Dec 2022 | 11450000000.00 |
| Apr 2023 | 10710000000.00 |
| Jul 2023 | 10687000000.00 |
| Sep 2023 | 10574000000.00 |
| Dec 2023 | 10886000000.00 |
| Mar 2024 | 10345000000.00 |
| Jun 2024 | 10541000000.00 |
| Sep 2024 | 10598000000.00 |
| Dec 2024 | 11395000000.00 |
| Mar 2025 | 10364000000.00 |
| Jun 2025 | 10855000000.00 |
| Sep 2025 | 11122000000.00 |
| Dec 2025 | 12215000000.00 |
| Mar 2026 | 11005000000.00 |
| Jun 2026 | 11994000000.00 |
Thermo Fisher Scientific's annual revenue was $44.56 B in fiscal year 2025.
Thermo Fisher Scientific's quarterly revenue was $10.36 B(Q1: Mar 2025), $10.86 B(Q2: Jun 2025), $11.12 B(Q3: Sep 2025), $12.22 B(Q4: Dec 2025) in fiscal year 2025.
Thermo Fisher Scientific's annual revenue was $42.88 B in fiscal year 2024.
Thermo Fisher Scientific's quarterly revenue was $10.35 B(Q1: Mar 2024), $10.54 B(Q2: Jun 2024), $10.60 B(Q3: Sep 2024), $11.40 B(Q4: Dec 2024) in fiscal year 2024.
Thermo Fisher Scientific's annual revenue was $42.86 B in fiscal year 2023.
Thermo Fisher Scientific's quarterly revenue was $10.71 B(Q1: Apr 2023), $10.69 B(Q2: Jul 2023), $10.57 B(Q3: Sep 2023), $10.89 B(Q4: Dec 2023) in fiscal year 2023.
Thermo Fisher Scientific's annual revenue was $44.92 B in fiscal year 2022.
Thermo Fisher Scientific's quarterly revenue was $11.82 B(Q1: Apr 2022), $10.97 B(Q2: Jul 2022), $10.68 B(Q3: Oct 2022), $11.45 B(Q4: Dec 2022) in fiscal year 2022.
Thermo Fisher Scientific's annual revenue was $39.21 B in fiscal year 2021.
Thermo Fisher Scientific's quarterly revenue was $9.91 B(Q1: Apr 2021), $9.27 B(Q2: Jul 2021), $9.33 B(Q3: Oct 2021), $10.70 B(Q4: Dec 2021) in fiscal year 2021.
Thermo Fisher Scientific's annual revenue was $32.22 B in fiscal year 2020.
Thermo Fisher Scientific's quarterly revenue was $6.23 B(Q1: Mar 2020), $6.92 B(Q2: Jun 2020), $8.52 B(Q3: Sep 2020), $10.55 B(Q4: Dec 2020) in fiscal year 2020.
Thermo Fisher Scientific's annual revenue was $25.54 B in fiscal year 2019.
Thermo Fisher Scientific's quarterly revenue was $6.13 B(Q1: Mar 2019), $6.32 B(Q2: Jun 2019), $6.27 B(Q3: Sep 2019), $6.83 B(Q4: Dec 2019) in fiscal year 2019.
Thermo Fisher Scientific's annual revenue was $24.36 B in fiscal year 2018.
Thermo Fisher Scientific's quarterly revenue was $5.85 B(Q1: Mar 2018), $6.08 B(Q2: Jun 2018), $5.92 B(Q3: Sep 2018), $6.51 B(Q4: Dec 2018) in fiscal year 2018.
Thermo Fisher Scientific's annual revenue was $20.92 B in fiscal year 2017.
Thermo Fisher Scientific's quarterly revenue was $4.77 B(Q1: Apr 2017), $4.99 B(Q2: Jul 2017), $5.12 B(Q3: Sep 2017), $6.05 B(Q4: Dec 2017) in fiscal year 2017.
Thermo Fisher Scientific's annual revenue was $18.27 B in fiscal year 2016.
Thermo Fisher Scientific's quarterly revenue was $4.29 B(Q1: Apr 2016), $4.54 B(Q2: Jul 2016), $4.49 B(Q3: Oct 2016), $4.95 B(Q4: Dec 2016) in fiscal year 2016.
| Year | Change |
|---|---|
| 2016 | +7.71 |
| 2017 | +14.47 |
| 2018 | +16.45 |
| 2019 | +4.86 |
| 2020 | +26.14 |
| 2021 | +21.71 |
| 2022 | +14.55 |
| 2023 | -4.58 |
| 2024 | +0.05 |
| 2025 | +3.91 |
| Period | Change |
|---|---|
| Q1: Apr 16 | 9.59 |
| Q2: Jul 16 | 6.19 |
| Q3: Oct 16 | 8.92 |
| Q4: Dec 16 | 6.46 |
| Q1: Apr 17 | 10.95 |
| Q2: Jul 17 | 10.03 |
| Q3: Sep 17 | 13.92 |
| Q4: Dec 17 | 22.08 |
| Q1: Mar 18 | 22.83 |
| Q2: Jun 18 | 21.80 |
| Q3: Sep 18 | 15.71 |
| Q4: Dec 18 | 7.61 |
| Q1: Mar 19 | 4.65 |
| Q2: Jun 19 | 3.92 |
| Q3: Sep 19 | 5.95 |
| Q4: Dec 19 | 4.95 |
| Q1: Mar 20 | 1.71 |
| Q2: Jun 20 | 9.52 |
| Q3: Sep 20 | 35.86 |
| Q4: Dec 20 | 54.49 |
| Q1: Apr 21 | 59.00 |
| Q2: Jul 21 | 34.06 |
| Q3: Oct 21 | 9.49 |
| Q4: Dec 21 | 1.44 |
| Q1: Apr 22 | 19.30 |
| Q2: Jul 22 | 18.30 |
| Q3: Oct 22 | 14.44 |
| Q4: Dec 22 | 6.99 |
| Q1: Apr 23 | -9.38 |
| Q2: Jul 23 | -2.58 |
| Q3: Sep 23 | -0.96 |
| Q4: Dec 23 | -4.93 |
| Q1: Mar 24 | -3.41 |
| Q2: Jun 24 | -1.37 |
| Q3: Sep 24 | 0.23 |
| Q4: Dec 24 | 4.68 |
| Q1: Mar 25 | 0.18 |
| Q2: Jun 25 | 2.98 |
| Q3: Sep 25 | 4.94 |
| Q4: Dec 25 | 7.20 |
| Q1: Mar 26 | 6.18 |
| Q2: Jun 26 | 10.49 |
Thermo Fisher Scientific’s annual revenue increased +3.91% during fiscal year 2025 compared to 2024. It represents a growth of $1.68 B from $42.88 B (in 2024) to $44.56 B (in 2025).
Thermo Fisher Scientific’s annual revenue increased +0.05% during fiscal year 2024 compared to 2023. It represents a growth of $22.00 M from $42.86 B (in 2023) to $42.88 B (in 2024).
Thermo Fisher Scientific’s annual revenue decreased -4.58% during fiscal year 2023 compared to 2022. It represents a decline of $2.06 B from $44.92 B (in 2022) to $42.86 B (in 2023).
Thermo Fisher Scientific’s annual revenue increased +14.55% during fiscal year 2022 compared to 2021. It represents a growth of $5.70 B from $39.21 B (in 2021) to $44.92 B (in 2022).
Thermo Fisher Scientific’s annual revenue increased +21.71% during fiscal year 2021 compared to 2020. It represents a growth of $6.99 B from $32.22 B (in 2020) to $39.21 B (in 2021).
Thermo Fisher Scientific’s annual revenue increased +26.14% during fiscal year 2020 compared to 2019. It represents a growth of $6.68 B from $25.54 B (in 2019) to $32.22 B (in 2020).
Thermo Fisher Scientific’s annual revenue increased +4.86% during fiscal year 2019 compared to 2018. It represents a growth of $1.18 B from $24.36 B (in 2018) to $25.54 B (in 2019).
Thermo Fisher Scientific’s annual revenue increased +16.45% during fiscal year 2018 compared to 2017. It represents a growth of $3.44 B from $20.92 B (in 2017) to $24.36 B (in 2018).
Thermo Fisher Scientific’s annual revenue increased +14.47% during fiscal year 2017 compared to 2016. It represents a growth of $2.64 B from $18.27 B (in 2016) to $20.92 B (in 2017).
Thermo Fisher Scientific’s annual revenue increased +7.71% during fiscal year 2016 compared to 2015. It represents a growth of $1.31 B from $16.97 B (in 2015) to $18.27 B (in 2016).
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free 
FY 2025
|
$44.56 B |
$1.68 B
3.91%
|
| Q4: Dec 25 | $12.22 B |
$820.00 M
7.2%
|
| Q3: Sep 25 | $11.12 B |
$524.00 M
4.94%
|
| Q2: Jun 25 | $10.86 B |
$314.00 M
2.98%
|
| Q1: Mar 25 | $10.36 B |
$19.00 M
0.18%
|
|
Get instant access to data, Sign up for free
FY 2024
|
$42.88 B |
$22.00 M
0.05%
|
| Q4: Dec 24 | $11.40 B |
$509.00 M
4.68%
|
| Q3: Sep 24 | $10.60 B |
$24.00 M
0.23%
|
| Q2: Jun 24 | $10.54 B |
-$146.00 M
1.37%
|
| Q1: Mar 24 | $10.35 B |
-$365.00 M
3.41%
|
|
Get instant access to data, Sign up for free
FY 2023
|
$42.86 B |
-$2.06 B
4.58%
|
| Q4: Dec 23 | $10.89 B |
-$564.00 M
4.93%
|
| Q3: Sep 23 | $10.57 B |
-$103.00 M
0.96%
|
| Q2: Jul 23 | $10.69 B |
-$283.00 M
2.58%
|
| Q1: Apr 23 | $10.71 B |
-$1.11 B
9.38%
|
|
Get instant access to data, Sign up for free
FY 2022
|
$44.92 B |
$5.70 B
14.55%
|
| Q4: Dec 22 | $11.45 B |
$748.00 M
6.99%
|
| Q3: Oct 22 | $10.68 B |
$1.35 B
14.44%
|
| Q2: Jul 22 | $10.97 B |
$1.70 B
18.3%
|
| Q1: Apr 22 | $11.82 B |
$1.91 B
19.3%
|
|
Get instant access to data, Sign up for free
FY 2021
|
$39.21 B |
$6.99 B
21.71%
|
| Q4: Dec 21 | $10.70 B |
$152.00 M
1.44%
|
| Q3: Oct 21 | $9.33 B |
$809.00 M
9.49%
|
| Q2: Jul 21 | $9.27 B |
$2.36 B
34.06%
|
| Q1: Apr 21 | $9.91 B |
$3.68 B
59%
|
|
Get instant access to data, Sign up for free
FY 2020
|
$32.22 B |
$6.68 B
26.14%
|
| Q4: Dec 20 | $10.55 B |
$3.72 B
54.49%
|
| Q3: Sep 20 | $8.52 B |
$2.25 B
35.86%
|
| Q2: Jun 20 | $6.92 B |
$601.00 M
9.52%
|
| Q1: Mar 20 | $6.23 B |
$105.00 M
1.71%
|
|
Get instant access to data, Sign up for free
FY 2019
|
$25.54 B |
$1.18 B
4.86%
|
| Q4: Dec 19 | $6.83 B |
$322.00 M
4.95%
|
| Q3: Sep 19 | $6.27 B |
$352.00 M
5.95%
|
| Q2: Jun 19 | $6.32 B |
$238.00 M
3.92%
|
| Q1: Mar 19 | $6.13 B |
$272.00 M
4.65%
|
|
Get instant access to data, Sign up for free
FY 2018
|
$24.36 B |
$3.44 B
16.45%
|
| Q4: Dec 18 | $6.51 B |
$460.00 M
7.61%
|
| Q3: Sep 18 | $5.92 B |
$803.80 M
15.71%
|
| Q2: Jun 18 | $6.08 B |
$1.09 B
21.8%
|
| Q1: Mar 18 | $5.85 B |
$1.09 B
22.83%
|
|
Get instant access to data, Sign up for free
FY 2017
|
$20.92 B |
$2.64 B
14.47%
|
| Q4: Dec 17 | $6.05 B |
$1.09 B
22.08%
|
| Q3: Sep 17 | $5.12 B |
$625.30 M
13.92%
|
| Q2: Jul 17 | $4.99 B |
$454.80 M
10.03%
|
| Q1: Apr 17 | $4.77 B |
$470.20 M
10.95%
|
|
Get instant access to data, Sign up for free
FY 2016
|
$18.27 B |
$1.31 B
7.71%
|
| Q4: Dec 16 | $4.95 B |
$300.70 M
6.46%
|
| Q3: Oct 16 | $4.49 B |
$367.70 M
8.92%
|
| Q2: Jul 16 | $4.54 B |
$264.30 M
6.19%
|
| Q1: Apr 16 | $4.29 B |
$376.00 M
9.59%
|
Agilent Technologies Revenue
Eli Lilly and Company Revenue
Stryker Corporation Revenue
Johnson & Johnson Revenue
AbbVie Revenue
Merck & Co. Revenue
Abbott Laboratories Revenue
Danaher Corporation Revenue
Amgen Revenue
